Published in

Royal Society of Chemistry, RSC Chemical Biology, 4(2), p. 1206-1220, 2021

DOI: 10.1039/d1cb00104c

Links

Tools

Export citation

Search in Google Scholar

Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

LRG1 is present abundantly in the microenvironment of many tumours. LRG1 targeting through the reported non-internalising ADC presents a novel and effective proof-of-concept en route to improving the efficacy of cancer therapeutics.